← Browse by Condition
Medical Condition
colorectal carcinoma
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for colorectal carcinoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — colorectal carcinoma Clinical Trials
How many clinical trials are currently recruiting for colorectal carcinoma?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for colorectal carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for colorectal carcinoma?
colorectal carcinoma research spans Phase 1 (2 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a colorectal carcinoma clinical trial?
Eligibility criteria for colorectal carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 3
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05410977
Recruiting
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Enrollment
750 pts
Location
United States
Sponsor
Mayo Clinic
NCT06603376 Phase 2
Recruiting
Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
Enrollment
75 pts
Location
China
Sponsor
Shanghai Changzheng Hospital
NCT06926374
Recruiting
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Enrollment
90 pts
Location
China
Sponsor
Chinese University of Hong Kon...
NCT06063928
Recruiting
Confronting Cancer as a Community
Enrollment
500 pts
Location
United States
Sponsor
University of Southern Califor...
NCT05663203
Recruiting
A Web-Based Dyadic Intervention for Colorectal Cancer
Enrollment
56 pts
Location
United States
Sponsor
Emory University
NCT06882746 Phase 1
Recruiting
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Enrollment
135 pts
Location
United States
Sponsor
Boehringer Ingelheim
NCT05630794 Phase 1
Recruiting
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06557733 Phase 2
Recruiting
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Enrollment
38 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07405476 Phase 2
Recruiting
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Enrollment
38 pts
Location
United States
Sponsor
Emory University
NCT06703632
Recruiting
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
Enrollment
4,538 pts
Location
Portugal, Spain
Sponsor
ADVANCED MARKER DISCOVERY S.L.
NCT07035691
Recruiting
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
Enrollment
582 pts
Location
United Kingdom
Sponsor
Queen Mary University of Londo...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology